-+ 0.00%
-+ 0.00%
-+ 0.00%

Pasithea Therapeutics Unveils Investor Presentation Highlighting Next-Generation MEK Inhibitor PAS-004 for Cancer and NF1

Reuters·01/12/2026 04:26:33

Please log in to view news